LYRA THERAPEUTICS INC lost $18.62 per diluted share in fiscal year 2025. This represents an increase of 74.0% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters LYRA THERAPEUTICS INC has filed alongside them.
FY2025 annual
EPS (Diluted)-$18.62
YoY+74.0%
Source SEC Filings (10-K/10-Q)Latest period FY2025, ended Dec 31, 2025ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
LYRA EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was LYRA THERAPEUTICS INC's diluted earnings per share in fiscal year 2025?
LYRA THERAPEUTICS INC lost $18.62 per diluted share in fiscal year 2025.
How fast is LYRA THERAPEUTICS INC's diluted earnings per share growing?
LYRA THERAPEUTICS INC (LYRA) diluted earnings per share rose by 74.0% year over year, from -$71.75 to -$18.62 in fiscal year 2025.
What was LYRA THERAPEUTICS INC's diluted earnings per share in the most recent quarter?
LYRA THERAPEUTICS INC (LYRA) reported -$3.77 in diluted earnings per share in Q4 2025.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what LYRA THERAPEUTICS INC (LYRA) reported on that line in every period on record.
